Indexiq Advisors buys $3,799,671 stake in Alere Inc (ALR)

Alere Inc (ALR) : Indexiq Advisors scooped up 78,493 additional shares in Alere Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 93,935 shares of Alere Inc which is valued at $3,799,671.Alere Inc makes up approximately 0.22% of Indexiq Advisors’s portfolio.

Other Hedge Funds, Including , Teachers Advisors Inc boosted its stake in ALR in the latest quarter, The investment management firm added 10,755 additional shares and now holds a total of 104,280 shares of Alere Inc which is valued at $4,218,126. Alere Inc makes up approx 0.01% of Teachers Advisors Inc’s portfolio.Jennison Associates reduced its stake in ALR by selling 461,170 shares or 60.74% in the most recent quarter. The Hedge Fund company now holds 298,071 shares of ALR which is valued at $11,100,164. Alere Inc makes up approx 0.01% of Jennison Associates’s portfolio.Kirr Marbach Co In reduced its stake in ALR by selling 6,566 shares or 1.77% in the most recent quarter. The Hedge Fund company now holds 364,185 shares of ALR which is valued at $11,460,902. Alere Inc makes up approx 2.30% of Kirr Marbach Co In’s portfolio.Gryphon International Investment Corp reduced its stake in ALR by selling 159,635 shares or 29.5% in the most recent quarter. The Hedge Fund company now holds 381,443 shares of ALR which is valued at $16,768,234. Alere Inc makes up approx 3.73% of Gryphon International Investment Corp’s portfolio.Creative Planning reduced its stake in ALR by selling 619 shares or 18.3% in the most recent quarter. The Hedge Fund company now holds 2,764 shares of ALR which is valued at $108,819.

Alere Inc opened for trading at $40.17 and hit $40.61 on the upside on Tuesday, eventually ending the session at $40.51, with a gain of 0.67% or 0.27 points. The heightened volatility saw the trading volume jump to 2,84,098 shares. Company has a market cap of $3,514 M.

On the company’s financial health, Alere Inc reported $-0.18 EPS for the quarter, missing the analyst consensus estimate by $ -0.73 based on the information available during the earnings call on Aug 17, 2016. Analyst had a consensus of $0.55. The company had revenue of $578.21 million for the quarter, compared to analysts expectations of $588.55 million. The company’s revenue was down -5.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.43 EPS.

Alere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics patient self-testing consumer diagnostics and corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time deliver care and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD) its 50/50 joint venture with The Procter & Gamble Company (P&G).

Leave a Reply

Alere Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Alere Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.